57.29% Net Profit Growth in First Half，Hengda Holds Leading Market Share

简体中文

86 0571-56256610

NEWS

Home page

Release time

2026-09-28

Author:

Hengda New Material (301469) has released its 2026 semi-annual report. During the reporting period, the company achieved operating revenue of RMB 548 million, a year-on-year increase of 5.16%. Net profit attributable to shareholders of the listed company stood at RMB 53.848 million, up 57.29% year-on-year, while net profit after deducting non-recurring gains and losses reached RMB 49.1342 million, a rise of 72.75%. Net cash flow from operating activities was RMB 44.5129 million, shifting from negative to positive year-on-year; both the company's profitability and operating cash flow improved.

The company focuses on the sector of base paper for medical and food packaging. During the reporting period, revenue from this segment reached RMB 482 million—up 7.16% year-on-year and accounting for 88.10% of total operating revenue—with a gross profit margin of 18.38%, an increase of 3.15 percentage points compared to the same period last year. With over twenty years of development, the company has established a strong market foundation in the mid-to-high-end primary packaging base paper sector for medical and food applications; its products target the mid-to-high-end market, and it holds a leading market share within the industry.

Regarding R&D and innovation, the company invested RMB 21.0768 million in the first half of the year, a year-on-year increase of 8.44%. Additionally, the company has established a comprehensive quality inspection system to support the expansion of its mid-to-high-end markets both domestically and internationally.

In overseas markets, the company has proactively advanced compliance efforts regarding the EU Deforestation Regulation (EUDR). Revenue from overseas operations continues to grow, with a primary focus on the mid-to-high-end medical and food packaging base paper markets.

As of the end of June 2026, the company's asset-liability ratio stood at 17.80%, maintaining a low level. Meanwhile, the company continues to advance green production and intelligent manufacturing, resulting in an improved ESG rating.

Looking ahead, the company will continue to deepen its product, technology, and market positioning within the mid-to-high-end medical and food packaging segments. It will concentrate on R&D and innovation to continuously enhance its core competitiveness, while also increasing production capacity to further consolidate and expand its market share.